UA71443U - Method for differential treatment of patients with psoriasis using microelement compositions - Google Patents
Method for differential treatment of patients with psoriasis using microelement compositionsInfo
- Publication number
- UA71443U UA71443U UAU201200455U UAU201200455U UA71443U UA 71443 U UA71443 U UA 71443U UA U201200455 U UAU201200455 U UA U201200455U UA U201200455 U UAU201200455 U UA U201200455U UA 71443 U UA71443 U UA 71443U
- Authority
- UA
- Ukraine
- Prior art keywords
- patients
- psoriasis
- compositions
- differential treatment
- microelement
- Prior art date
Links
- 201000004681 Psoriasis Diseases 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 abstract 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 2
- 229910052791 calcium Inorganic materials 0.000 abstract 2
- 239000011575 calcium Substances 0.000 abstract 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 abstract 1
- 229910052742 iron Inorganic materials 0.000 abstract 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 abstract 1
- 239000011701 zinc Substances 0.000 abstract 1
- 229910052725 zinc Inorganic materials 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A method for the complex treatment of patients with psoriasis provides for the use of microelements, namely iron, calcium, manganese, zinc. A compositions of Totema, Zincteral, Ferrum lek and Calcium D3 Nicomed forte are used with this aim.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201200455U UA71443U (en) | 2012-01-16 | 2012-01-16 | Method for differential treatment of patients with psoriasis using microelement compositions |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201200455U UA71443U (en) | 2012-01-16 | 2012-01-16 | Method for differential treatment of patients with psoriasis using microelement compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA71443U true UA71443U (en) | 2012-07-10 |
Family
ID=50848476
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAU201200455U UA71443U (en) | 2012-01-16 | 2012-01-16 | Method for differential treatment of patients with psoriasis using microelement compositions |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA71443U (en) |
-
2012
- 2012-01-16 UA UAU201200455U patent/UA71443U/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2018260809A1 (en) | Compounds and uses thereof for the modulation of hemoglobin | |
| CA2900779C (en) | Compositions and methods for treating neurodegenerative diseases and cardiomyopathy | |
| TR201813877T4 (en) | COMPOUNDS FOR TREATMENT OF SPINAL MUSCULAR ATROPHY. | |
| PH12015500525A1 (en) | Formulations of enzalutamide | |
| MX2016006103A (en) | Theacrine-based supplement and method of use thereof. | |
| EP4420727A3 (en) | Bispecific egfr/c-met antibodies | |
| MX2014011134A (en) | Carbamate compounds and of making and using same. | |
| MX2016014306A (en) | Hdl therapy markers. | |
| MX2015011509A (en) | Compounds and uses thereof for the modulation of hemoglobin. | |
| WO2013177187A3 (en) | Synergistic tumor treatment with extended-pk il-2 and therapeutic agents | |
| NZ727304A (en) | Compositions and methods of use of phorbol esters for the treatment of stroke | |
| PH12014501605A1 (en) | Anti-lrp5 antibodies and methods of use | |
| HK1212221A1 (en) | Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer | |
| AU360965S (en) | Ventilator for medical use | |
| MX356755B (en) | Fumigillol type compounds and methods of making and using same. | |
| MX354303B (en) | Anti-biotin antibodies and methods of use. | |
| GB2498325A (en) | Modulation neural pathways | |
| PE20190305A1 (en) | PROCEDURE FOR THE MANUFACTURE OF BRIQUETTES CONTAINING A CALCIUM-MAGNESIAN COMPOUND AND AN IRON-BASED COMPOUND, AND BRIQUETTES SO OBTAINED | |
| MX2017003953A (en) | High-coverage, low odor malodor counteractant compounds and methods of use. | |
| AU358035S (en) | Valve | |
| EA201491894A1 (en) | METHODS OF TREATMENT OF Lactose Intolerance | |
| MX2016015163A (en) | Mit biomarkers and methods using the same. | |
| MX2016009241A (en) | Methods of reducing malodor and bacteria. | |
| ZA201708686B (en) | Nanoparticles for use as a therapeutic vaccine | |
| MX357675B (en) | Anti-jagged anitbodies and methods of use. |